Pathologic Fractures
Pathologic Fractures Timothy A. Damron A pathologic fracture is defined as one occurring in abnormal bone. The abnormality in the bone may be due to metabolic diseases (such as osteoporosis,…
Pathologic Fractures Timothy A. Damron A pathologic fracture is defined as one occurring in abnormal bone. The abnormality in the bone may be due to metabolic diseases (such as osteoporosis,…
Malignant Bone Lesions Francis R. Patterson Timothy A. Damron Carol D. Morris Malignancies involving bone include metastatic disease, myeloma, lymphoma, and bone sarcoma. Treatment options include surgery, radiotherapy, and chemotherapy….
Soft Tissue Tumors John Heiner Jeremy White The treatment of soft tissue tumors is dictated strictly by the diagnosis. Based on the pathology of the tumor, appropriate treatment can involve…
Benign Tumors of Bone Cynthia M. Kelly Musculoskeletal tumors are, in general, uncommon problems, and malignant tumors of bone are considered rare. Comparatively speaking, benign tumors of bone are more…
Surgical Margins Robert Quinn Appropriate surgical planning for the treatment of musculoskeletal tumors requires proper histologic diagnosis and staging. The type of surgical margin most appropriate for a given tumor…
Biopsy of Musculoskeletal Tumors Edward A. Athanasian Biopsy of musculoskeletal bone and soft tissue tumors may appear to be a deceptively easy technical surgical procedure. Patients may also perceive biopsy…
Evaluation of Soft Tissue Tumors Carol D. Morris Soft tissue tumors are heterogeneous in their behavior and management. The vast majority of soft tissue tumors are benign, with benign tumors…
Evaluation of Bone Tumors Timothy A. Damron Bone lesions can be difficult to identify specifically, and arriving at a specific diagnosis can elude even the most experienced orthopaedic oncologist. However,…
Unit III. Combination Chemotherapy Regimens The use of combination chemotherapy is well established. Combining agents have allowed the clinician to achieve maximum cell kill while trying to minimize toxicity to…
♦Vinorelbine (vin-oh-rel-been’) Navelbine Pregnancy Category D Mechanism of Action An antimitotic agent that inhibits microtubule formation by interfering with nucleic acid synthesis. Indications Non-small cell lung cancer, breast cancer, ovarian…